These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1063 related items for PubMed ID: 28612180

  • 1. Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review.
    Strand V, Balsa A, Al-Saleh J, Barile-Fabris L, Horiuchi T, Takeuchi T, Lula S, Hawes C, Kola B, Marshall L.
    BioDrugs; 2017 Aug; 31(4):299-316. PubMed ID: 28612180
    [Abstract] [Full Text] [Related]

  • 2. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.
    Wu N, Lee YC, Shah N, Harrison DJ.
    Clin Ther; 2014 Aug 01; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients.
    Chastek B, White J, Van Voorhis D, Tang D, Stolshek BS.
    Adv Ther; 2016 Apr 01; 33(4):626-42. PubMed ID: 26970958
    [Abstract] [Full Text] [Related]

  • 5. Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.
    Valido A, Silva-Dinis J, Saavedra MJ, Iria I, Gonçalves J, Lopes JP, Fonseca JE.
    Acta Reumatol Port; 2019 Apr 01; 44(4):303-311. PubMed ID: 31754088
    [Abstract] [Full Text] [Related]

  • 6. SB5: An Adalimumab Biosimilar.
    Frampton JE.
    BioDrugs; 2018 Oct 01; 32(5):507-510. PubMed ID: 30251234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG, Pontikaki I, Becciolini A, Biggioggero M, Ughi N, Romano M, Crotti C, Gattinara M, Gerloni V, Marchesoni A, Meroni PL.
    Clin Rheumatol; 2017 Aug 01; 36(8):1747-1755. PubMed ID: 28597133
    [Abstract] [Full Text] [Related]

  • 9. CT-P13: design, development, and place in therapy.
    Gabbani T, Deiana S, Annese V.
    Drug Des Devel Ther; 2017 Aug 01; 11():1653-1661. PubMed ID: 28652703
    [Abstract] [Full Text] [Related]

  • 10. Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence.
    Jacobs I, Petersel D, Isakov L, Lula S, Lea Sewell K.
    BioDrugs; 2016 Dec 01; 30(6):525-570. PubMed ID: 27885553
    [Abstract] [Full Text] [Related]

  • 11. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
    Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2017 May 08; 5(5):CD012657. PubMed ID: 28481462
    [Abstract] [Full Text] [Related]

  • 12. Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis.
    Liu Y, Wu EQ, Bensimon AG, Fan CP, Bao Y, Ganguli A, Yang M, Cifaldi M, Mulani P.
    Adv Ther; 2012 Jul 08; 29(7):620-34. PubMed ID: 22843208
    [Abstract] [Full Text] [Related]

  • 13. Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis.
    Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW.
    J Med Econ; 2016 Jul 08; 19(1):34-43. PubMed ID: 26337538
    [Abstract] [Full Text] [Related]

  • 14. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N.
    Health Technol Assess; 2011 Feb 08; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [Abstract] [Full Text] [Related]

  • 15. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M, Joseph GJ, Princic N, Harrison DJ.
    J Med Econ; 2013 Sep 08; 16(9):1120-8. PubMed ID: 23808901
    [Abstract] [Full Text] [Related]

  • 16. A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
    Glintborg B, Sørensen IJ, Loft AG, Lindegaard H, Linauskas A, Hendricks O, Hansen IMJ, Jensen DV, Manilo N, Espesen J, Klarlund M, Grydehøj J, Dieperink SS, Kristensen S, Olsen JS, Nordin H, Chrysidis S, Dalsgaard Pedersen D, Sørensen MV, Andersen LS, Grøn KL, Krogh NS, Pedersen L, Hetland ML, all departments of rheumatology in Denmark.
    Ann Rheum Dis; 2017 Aug 08; 76(8):1426-1431. PubMed ID: 28473425
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Ascef BO, Almeida MO, Medeiros-Ribeiro AC, Oliveira de Andrade DC, Oliveira Junior HA, de Soárez PC.
    JAMA Netw Open; 2023 May 01; 6(5):e2315872. PubMed ID: 37234004
    [Abstract] [Full Text] [Related]

  • 18. Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.
    Emery P, Suh CH, Weinblatt ME, Smolen JS, Keystone EC, Genovese M, Vencovsky J, Kay J, Hong E, Baek Y, Ghil J.
    Scand J Rheumatol; 2020 Sep 01; 49(5):361-370. PubMed ID: 32468892
    [Abstract] [Full Text] [Related]

  • 19. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2015 Apr 18; 2015(4):CD005468. PubMed ID: 25887212
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.